Met Life Investment Management, LLC Nautilus Biotechnology, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,613 shares of NAUT stock, worth $54,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,613
Previous 0
Infinity%
Holding current value
$54,491
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NAUT
# of Institutions
86Shares Held
64.3MCall Options Held
1.9KPut Options Held
100-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$29 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$22.4 Million0.94% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$12.8 Million0.51% of portfolio
-
Madrona Venture Group, LLC6.02MShares$10.7 Million23.0% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$6.81 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $222M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...